Brooklyn ImmunoTherapeutics (BTX) Stock Chart & Stock Price History $7.31 -0.01 (-0.14%) As of 08/1/2025 03:59 PM Eastern Add Share Share Chart Stock AnalysisChartCompetitorsDividendHeadlinesSEC FilingsTrendsBuy This Stock Brooklyn ImmunoTherapeutics Stock Price Performance The Brooklyn ImmunoTherapeutics (BTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 310.67%, with a year-to-date return of 2,789.33%. In the past month, the stock has decreased 0.68%, reflecting recent market activity. As of the latest close, Brooklyn ImmunoTherapeutics traded at $7.31 with a market cap of $430.02 million and volume of 754,552 shares. Receive BTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.69%1 Month Performance-0.68%3 Month Performance+13.86%Year-To-Date Performance+2,789.33%1 Year Performance+310.67% BTX Stock Chart for Monday, August, 4, 2025 BTX Chart by TradingView Brooklyn ImmunoTherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$7.31$7.31$7.32$7.16754,552 shs$430.02 million07/31/2025$7.26$7.31+0.69%$7.38$7.26589,730 shs$430.02 million07/30/2025$7.23$7.26+0.41%$7.30$7.22312,601 shs$427.08 million07/29/2025$7.28$7.23-0.69%$7.34$7.20305,062 shs$425.31 million07/28/2025$7.32$7.28-0.55%$7.37$7.27386,770 shs$428.25 million07/25/2025$7.31$7.32+0.14%$7.33$7.27270,789 shs$430.61 million07/24/2025$7.30$7.31+0.14%$7.32$7.23343,800 shs$430.02 million07/23/2025$7.28$7.30+0.27%$7.32$7.23333,262 shs$429.43 million07/22/2025$7.36$7.28-1.09%$7.37$7.27451,685 shs$428.25 million07/21/2025$7.49$7.36-1.74%$7.43$7.35723,036 shs$432.96 million Get the Latest News and Ratings for BTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$7.22$7.49+3.74%$7.50$7.111.54 million shs$440.61 million07/17/2025$7.16$7.22+0.84%$7.24$7.07788,432 shs$424.72 million07/16/2025$7.14$7.16+0.28%$7.18$7.09576,786 shs$421.19 million07/15/2025$7.09$7.14+0.71%$7.15$7.05536,945 shs$420.02 million07/14/2025$7.08$7.09+0.14%$7.12$6.94914,025 shs$417.08 million07/11/2025$7.21$7.08-1.80%$7.20$7.02525,137 shs$416.49 million07/10/2025$7.24$7.21-0.41%$7.30$7.20374,416 shs$424.14 million07/09/2025$7.29$7.24-0.69%$7.31$7.22501,880 shs$425.90 million07/08/2025$7.33$7.29-0.55%$7.33$7.27523,539 shs$428.84 million07/07/2025$7.36$7.33-0.41%$7.37$7.291.06 million shs$431.20 million07/04/2025$7.36$7.36$7.37$7.29488,490 shs$432.96 million07/03/2025$7.30$7.36+0.82%$7.37$7.29488,490 shs$432.96 million This page (NYSE:BTX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
